Alexza Pharmaceuticals Inc.
Healthcare · Pharmaceutical Preparations · DE · SEC filings ↗ · Compare ⊕
Financials
SEC XBRL · annual| FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | |
|---|---|---|---|---|---|---|
| Revenue | $705,000 | $2.2M | $47.8M | $4.1M | $65.5M | $42.9M |
| Operating income | −$13.0M | −$8.8M | $1.8M | −$28.9M | −$34.4M | −$4.7M |
| Net income | −$404,000 | −$10.7M | −$39.6M | −$28.0M | −$40.5M | −$1.5M |
| Total assets | $14.7M | $61.6M | $47.1M | $40.6M | $48.6M | $68.5M |
| Total liabilities | — | — | — | — | — | — |
| Equity | −$71.7M | −$51.7M | −$24.0M | $2.6M | −$9.7M | $12.3M |
| EPS (diluted) | — | — | — | — | — | — |
| Shares out. | 19.4M | 17.3M | 15.8M | 116.1M | 7.2M | 59.8M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2015- Operating margin
- −1844.4%
- Net margin
- −57.3%
- Return on equity
- 0.6%
- Return on assets
- −2.7%
- Return on capital (ROCE)
- —
- Liabilities / assets
- —
- Debt / equity
- —
- Book value / share
- $-3.69
- Revenue growth (YoY)
- −67.5%
- Net income growth (YoY)
- —
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2015- Accruals / assets
- 213.7%high accruals
- Piotroski F-Score
- 2/8weak
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast. What these scores mean →
Signs
● 1 severe● 5 warning● 0 good- Negative shareholder equity
- Operating losses (negative operating margin)
- Reported a net loss
- Revenue declined year-over-year
- Negative operating cash flow
- High accruals — earnings-quality risk
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Insider transactions
SEC Form 4 · most recent| Insider | Date | Type | Shares | Price |
|---|---|---|---|---|
| Ringold GordonDirector | Jun 21, 2016 | U | 32,392 | — |
| Grupo Ferrer Internacional, S.A.10% owner | Sep 28, 2015 | Buy | 125,000 | — |
Headline trade per Form 4 (officers, directors, 10%+ owners). Buy/sell read from the filing's structured data — blank where a field isn't cleanly tagged.
Material events
SEC Form 8-K · most recent- Delisting / listing-standard noticeJul 1, 2016
- Entered a material agreement · Terminated a material agreementJun 24, 2016
- Completed an acquisition or disposition · Delisting / listing-standard notice · Modified shareholder rights · Change in control · Director / officer change · Amended charter or bylaws · Other material eventJun 21, 2016
- Delisting / listing-standard noticeJun 16, 2016
- Results of operationsMay 11, 2016
- Entered a material agreement · Terminated a material agreement · Other material eventMay 10, 2016
- Results of operationsMar 28, 2016
- Other material eventMar 9, 2016
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗Event-driven situations (1)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.